These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6217207)

  • 21. Functional assay of plasminogen activator by hydrolysis of 14C-globin.
    Finci Z; Nachshon I; Sharoni Y; Mayer M
    Exp Hematol; 1986 May; 14(4):293-7. PubMed ID: 2938980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of the urokinase-catalyzed activation of human plasminogen.
    Violand BN; Castellino FJ
    J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW; Ellis V; Dichek DA
    J Biol Chem; 1994 Jan; 269(4):2411-8. PubMed ID: 8300567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinolysis and the biliary tree.
    Scott-Coombes DM; Whawell SA; Havranek EG; Thompson JN
    Gut; 1997 Jan; 40(1):92-4. PubMed ID: 9155582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation.
    Geratz JD; Shaver SR; Tidwell RR
    Thromb Res; 1981 Oct 1-15; 24(1-2):73-83. PubMed ID: 6460342
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enzymatic fibrinolytic agents].
    Jamet M; Granthil C; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
    Robbins KC; Tanaka Y
    Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.
    Gilbert LC; Wachsman JT
    Biochim Biophys Acta; 1982 Jun; 704(3):450-60. PubMed ID: 7052133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
    J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the conversion of high molecular weight urokinase to the low molecular weight form by plasmin.
    Barlow GH; Francis CW; Marder VJ
    Thromb Res; 1981 Sep; 23(6):541-7. PubMed ID: 6459663
    [No Abstract]   [Full Text] [Related]  

  • 35. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.
    Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E
    Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids.
    Peltz SW; Hardt TA; Mangel WF
    Biochemistry; 1982 May; 21(11):2798-804. PubMed ID: 6212078
    [No Abstract]   [Full Text] [Related]  

  • 37. The hydrolysis of alpha-CBZ-L-lysine-p-nitrophenyl ester by two forms of human urokinase.
    Ascenzi P; Bertollini A; Verzili D; Brunori M; Antonini E
    Anal Biochem; 1980 Apr; 103(2):235-9. PubMed ID: 6770709
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
    Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
    J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
    Petersen LC; Brender J; Suenson E
    Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sensitive, coupled assay for plasminogen activator using a thiol ester substrate for plasmin.
    Coleman PL; Green GD
    Ann N Y Acad Sci; 1981; 370():617-26. PubMed ID: 6267977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.